NexChron

Subscribe

Top Stories

Latest News Business Government & Policy Healthcare Work & Labor

All Sections

AI News Business & Enterprise Government & Policy Healthcare & Wellness Education & Learning Transportation & Logistics Home & Consumer Finance & Banking Energy & Climate Creative & Media Security & Privacy Science & Research Work & Labor Legal & Compliance Agriculture & Food Manufacturing & Industry Real Estate & Construction Retail & Commerce Telecom & Connectivity Social Impact & Ethics

Learn

AI for Everyone AI Glossary AI Encyclopedia AI Answers Industry Guides Learning Paths

Intelligence

AI Company Hub AI Models AI Funding Tracker AI Comparisons Regulation Tracker

Finance

AI Stock Tracker AI IPO Watch

Tools

AI Readiness Quiz AI Tool Finder AI Model Selector

About

About NexChron Newsletter RSS Feed

Subscribe — Free Daily Briefing

Search

1 results for "cancer monitoring"

A medical facility featuring patient, monitor, related to Personalis for $1.5 Billion to Expand Into Cancer Recurrence from an unusual angle or perspective

Healthcare & Wellness · 3 min read

Tempus AI Acquires Personalis for $1.5 Billion to Expand Into Cancer Recurrence Monitoring

Tempus AI's $1.5 billion acquisition of Personalis combines AI-powered cancer diagnosis with molecular residual disease testing to create an integrated surveillance platform for post-treatment recurrence monitoring.